Association between pre-diagnostic serum uric acid levels in patients with newly diagnosed epilepsy and conversion rate to drug-resistant epilepsy within 5 years: A common data model analysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Koh, Seungyon | - |
dc.contributor.author | Lee, Dong Yun | - |
dc.contributor.author | Cha, Jae Myung | - |
dc.contributor.author | Kim, Yerim | - |
dc.contributor.author | Kim, Hyung Hoi | - |
dc.contributor.author | Yang, Hyeon-Jong | - |
dc.contributor.author | Park, Rae Woong | - |
dc.contributor.author | Choi, Jun Young | - |
dc.date.accessioned | 2024-06-11T08:30:56Z | - |
dc.date.available | 2024-06-11T08:30:56Z | - |
dc.date.issued | 2024-05 | - |
dc.identifier.issn | 1059-1311 | - |
dc.identifier.issn | 1532-2688 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/26292 | - |
dc.description.abstract | Purpose: Drug -resistant epilepsy (DRE) poses a significant challenge in epilepsy management, and reliable biomarkers for identifying patients at risk of DRE are lacking. This study aimed to investigate the association between serum uric acid (UA) levels and the conversion rate to DRE. Methods: A retrospective cohort study was conducted using a common data model database. The study included patients newly diagnosed with epilepsy, with prediagnostic serum UA levels within a six-month window. Patients were categorized into hyperUA (>= 7.0 mg/dL), normoUA ( <7.0 and >2.0 mg/dL), and hypoUA (<= 2.0 mg/dL) groups based on their prediagnostic UA levels. The outcome was the conversion rate to DRE within five years of epilepsy diagnosis. Results: The study included 5,672 patients with epilepsy and overall conversion rate to DRE was 19.4%. The hyperUA group had a lower DRE conversion rate compared to the normoUA group (HR: 0.81 [95% CI: 0.69 -0.96]), while the hypoUA group had a higher conversion rate (HR: 1.88 [95% CI: 1.38 -2.55]). Conclusions: Serum UA levels have the potential to serve as a biomarker for identifying patients at risk of DRE, indicating a potential avenue for novel therapeutic strategies aimed at preventing DRE conversion. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | W B SAUNDERS CO LTD | - |
dc.title | Association between pre-diagnostic serum uric acid levels in patients with newly diagnosed epilepsy and conversion rate to drug-resistant epilepsy within 5 years: A common data model analysis | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1016/j.seizure.2024.04.014 | - |
dc.identifier.scopusid | 2-s2.0-85191186975 | - |
dc.identifier.wosid | 001234407400001 | - |
dc.identifier.bibliographicCitation | SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, v.118, pp 103 - 109 | - |
dc.citation.title | SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | - |
dc.citation.volume | 118 | - |
dc.citation.startPage | 103 | - |
dc.citation.endPage | 109 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | URATE | - |
dc.subject.keywordPlus | HYPERURICEMIA | - |
dc.subject.keywordPlus | PREDICTOR | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | ADULTS | - |
dc.subject.keywordAuthor | Uric acid | - |
dc.subject.keywordAuthor | Drug-resistant epilepsy | - |
dc.subject.keywordAuthor | Neuroprotection | - |
dc.subject.keywordAuthor | Common data model | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.